Filing Details

Accession Number:
0000914190-17-000163
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-06-02 16:07:03
Reporting Period:
2017-05-31
Filing Date:
2017-06-02
Accepted Time:
2017-06-02 16:07:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1180145 Cardiovascular Systems Inc CSII Surgical & Medical Instruments & Apparatus (3841) 411698056
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1428164 A. Paul Koehn 1225 Old Highway 8 Nw
St. Paul MN 55112
Svp Manufacturing & Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-05-31 12,940 $7.90 96,929 No 4 M Direct
Common Stock Acquisiton 2017-05-31 7,060 $12.15 103,989 No 4 M Direct
Common Stock Disposition 2017-05-31 20,000 $29.98 83,989 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2017-05-31 12,940 $0.00 12,940 $7.90
Common Stock Stock Option (right to buy) Disposition 2017-05-31 7,060 $0.00 7,060 $12.15
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2017-10-08 No 4 M Direct
17,060 2017-12-11 No 4 M Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (right to buy) $8.75 2019-03-01 8,087 8,087 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2019-03-01 8,087 8,087 Direct
Footnotes
  1. Includes 602 shares acquired under Cardiovascular Systems, Inc.'s stock purchase plan on December 31, 2016.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.96 to $30.01 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. Fully exercisable.